Status:

TERMINATED

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

Lead Sponsor:

Vanderbilt University

Conditions:

Wound Infection

Eligibility:

FEMALE

18-50 years

Phase:

NA

Brief Summary

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effe...

Eligibility Criteria

Inclusion

  • Cesarean delivery with pfannenstiel incision

Exclusion

  • Incision other than pfannenstiel
  • Silver allergy
  • Inability to provide informed consent

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2012

Estimated Enrollment :

475 Patients enrolled

Trial Details

Trial ID

NCT01169064

Start Date

July 1 2010

End Date

July 1 2012

Last Update

May 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Hospital

Nashville, Tennessee, United States, 37232